Genvec Value Stock - Dividend - Research Selection
Market price: 0,00 USD
Genvec Fundamental data and company key figures of the share
|Annual reports in USD|
|Net operating cash flow||-5.983.000|
|Free cash flow||-6.002.000|
|Liabilities & Shareholders equity||7.707.000|
|Diluted shares outstanding||2.000.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||14.380.000,00 USD|
|Raw Data Source|
Description of the company
GenVec, Inc. develops gene-based pharmaceuticals and therapies for the treatment of major medical needs. The Company combines its patented gene transfer technologies with proprietary therapeutic genes to create product candidates that address needs in the areas of cardiovascular disease, cancer and other therapeutic areas.